Strategic partnership forms single-source solution for biopharma

By Melissa Fassbender

- Last updated on GMT

(Image: CSSi Life Sciences)
(Image: CSSi Life Sciences)

Related tags Infectious disease

CSSi LifeSciences and BioMARC have announced a strategic partnership to provide 'fully cohesive product development and support' for vaccine and biologic development. 

CSSi LifeSciences, an industry partner for discovery and commercialization of biologics and vaccines, announced the strategic partnership with the Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC​), a nonprofit contract manufacturing service run by Colorado State University.

"The goal of the partnership between CSSi LifeSciences and BioMARC is to provide our clients with the services, resources and solutions needed to help meet their needs for innovation and development programs related to the prevention, management and treatment of infectious diseases​," Jim Sergi, president, CSSi LifeSciences, told Outsourcing-Pharma.com.

"Such capabilities focus on development and manufacturing expertise, addressing the tough problems and challenging tasks in this field that do not exist broadly in the biopharma environment," ​Raymond Goodrich, PhD, Executive Director, Infectious Disease Research Center at BioMarc, added.

The companies' expertise ranges from preclinical testing, to cGMP production and on through late stage clinical trials as well as commercialization.

Dennis Pierro, PhD, Director, BioMARC, told us the benefit to clients is in the "fully cohesive product development support and regulatory guidance​," now available as part of the strategic partnership.

The official announcement was made at the CSSi LifeSciences Partnering Forum 2017, which took place yesterday at the J.P. Morgan 35th Annual Healthcare Conference.

Related news

Related products

show more

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 01-Jan-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Catalent | 06-Dec-2022 | Product Brochure

Your biologics possess a high level of complexities and technical challenges. That’s why development is key to ensuring the successful delivery of your...

Related suppliers

Follow us

Products

View more

Webinars